Neonatal Abstinence Syndrome

Download PDF

Recent Publications on Neonatal Abstinence Syndrome:
Pharmacological aspects of neonatal antidepressant withdrawal. Depression is common in reproductive age women, and continued...	2nd July, 2008	Department of Clinical Pharmacy, Isala Clinics, Zwolle, The Netherlands.	Obstet Gynecol Surv. 2008 Apr;63(4):267-79. DOI Direct Link
Neonatal Abstinence Syndrome. OBJECTIVE. TO STUDY THE SUBSTANCE MISUSE IN PREGNANT MOTHERS AND ITS...	28th June, 2008	The Great Western Hospital, 21 Tansley Moor, Swindon, SN3 6NA, Wiltshire,	Indian J Pediatr. 2008 Jun 25;. DOI Direct Link
Management of chemical dependence in pregnancy. Although the percentage of pregnant patients who use illicit drugs is...	28th June, 2008	Addiction Medicine Services, Detroit Medical Center, Wayne State	Clin Obstet Gynecol. 2008 Jun;51(2):445-55. DOI Direct Link
Prenatal methamphetamine use and neonatal neurobehavioral outcome. BACKGROUND: Methamphetamine (MA) use among pregnant women is an increasing...	24th June, 2008	Los Angeles Biomedical Institute at Harbor-UCLA Medical Center and David	Neurotoxicol Teratol. 2008 Jan-Feb;30(1):20-8. Epub 2007 Oct 3. DOI Direct Link
Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero. Aim: To study the neonatal outcome of infants exposed to buprenorphine in...	14th May, 2008	Hospital for Children and Adolescents, Helsinki University Central	Acta Paediatr. 2008 May 8;. DOI Direct Link
→View more research publications.

Neonatal Abstinence Syndrome Clinical Trials:
Buprenorphine for the Treatment of Neonatal Abstinence Syndrome	Neonatal Abstinence Syndrome
Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome	Neonatal Abstinence Syndrome
Vagal Tone and NAS	Neonatal Abstinence Syndrome;   Vagal Tone
The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome. - 1	Opiate Dependence;   Pregnancy
Maternal Acupuncture for Substance Abuse	Addiction Intervention: Procedure: Acupuncture
→View more trials.

BioPortfolio Ltd. offers e-mail and postal lists for Neonatal Abstinence Syndrome scientists - we have details of around 61 individuals working on Neonatal Abstinence Syndrome .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.